MENU
+Compare
SARTF
Stock ticker: OTC
AS OF
Dec 1 closing price
Price
$220.00
Change
+$23.51 (+11.96%)
Capitalization
17.72B

SARTF Sartorius AG Forecast, Technical & Fundamental Analysis

Sartorius AG is a leading provider of bioprocessing solutions... Show more

SARTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SARTF with price predictions
Dec 24, 2025

Momentum Indicator for SARTF turns positive, indicating new upward trend

SARTF saw its Momentum Indicator move above the 0 level on December 01, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 64 similar instances where the indicator turned positive. In of the 64 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SARTF moved above its 50-day moving average on December 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SARTF crossed bullishly above the 50-day moving average on December 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for SARTF turned negative on December 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

SARTF broke above its upper Bollinger Band on December 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SARTF entered a downward trend on December 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SARTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.826) is normal, around the industry mean (9.534). P/E Ratio (96.649) is within average values for comparable stocks, (167.335). Projected Growth (PEG Ratio) (0.756) is also within normal values, averaging (2.546). Dividend Yield (0.004) settles around the average of (0.017) among similar stocks. P/S Ratio (3.662) is also within normal values, averaging (112.419).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SARTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SARTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

SARTF paid dividends on March 31, 2021

Sartorius AG SARTF Stock Dividends
А dividend of $0.70 per share was paid with a record date of March 31, 2021, and an ex-dividend date of March 29, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Otto-Brenner-Strasse 20
Phone
+49 5513080
Employees
14614
Web
https://www.sartorius.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSMX47.860.56
+1.18%
Direxion Daily TSM Bull 2X Shares
THW13.130.14
+1.08%
abrdn World Healthcare Fund
UPW21.870.15
+0.71%
ProShares Ultra Utilities
PAI12.550.07
+0.56%
Western Asset Investment Grade Income Fund
TCAF38.530.14
+0.36%
T. Rowe Price Capital Apprec Eq ETF

SARTF and Stocks

Correlation & Price change

A.I.dvisor tells us that SARTF and SOAGY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SARTF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SOAGY - SARTF
25%
Poorly correlated
+0.32%
RVTY - SARTF
25%
Poorly correlated
-0.82%
SRTOY - SARTF
24%
Poorly correlated
N/A
EXAS - SARTF
24%
Poorly correlated
-0.05%
WAT - SARTF
21%
Poorly correlated
+0.42%
More

Groups containing SARTF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
Pharmaceuticals: Other
industry (102 stocks)
15%
Poorly correlated
+0.30%
Pharmaceuticals
industry (375 stocks)
14%
Poorly correlated
+0.36%